|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0034065,
umls-concept:C0042460,
umls-concept:C0149871,
umls-concept:C0180860,
umls-concept:C0205107,
umls-concept:C0600051,
umls-concept:C1257890,
umls-concept:C1512900,
umls-concept:C1708528,
umls-concept:C2603343
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1998-2-12
|
|
pubmed:abstractText |
The efficacy and safety of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis is still a matter of debate.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
pubmed-author:BarralF GFG,
pubmed-author:CharbonnierBB,
pubmed-author:DecoususHH,
pubmed-author:FaivreRR,
pubmed-author:GirardPP,
pubmed-author:HuetYY,
pubmed-author:LaporteSS,
pubmed-author:LeizoroviczAA,
pubmed-author:Pain,
pubmed-author:ParentFF,
pubmed-author:SimonneauGG,
pubmed-author:TardyBB
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
12
|
|
pubmed:volume |
338
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
409-15
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9459643-Aged,
pubmed-meshheading:9459643-Anticoagulants,
pubmed-meshheading:9459643-Combined Modality Therapy,
pubmed-meshheading:9459643-Enoxaparin,
pubmed-meshheading:9459643-Female,
pubmed-meshheading:9459643-Hemorrhage,
pubmed-meshheading:9459643-Heparin,
pubmed-meshheading:9459643-Humans,
pubmed-meshheading:9459643-Male,
pubmed-meshheading:9459643-Pulmonary Embolism,
pubmed-meshheading:9459643-Recurrence,
pubmed-meshheading:9459643-Survival Analysis,
pubmed-meshheading:9459643-Thrombophlebitis,
pubmed-meshheading:9459643-Treatment Outcome,
pubmed-meshheading:9459643-Vena Cava Filters
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.
|
|
pubmed:affiliation |
Clinical Pharmacology Unit, Bellevue Hospital, Saint-Etienne, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
